New findings by researchers carrying out experiments at the U.S. Department of Energy Office of Science's Advanced Photon Source (APS) help explain why some drugs that interact with two kinds of human serotonin receptors ...
May 17, 2013
0
126
(Medical Xpress) -- New international collaborative research led by Stanford University, the University of Michigan and involving Trinity College Dublin recently published in Nature, increases our understanding of how a ...
Oct 13, 2011
1
99
Researchers at Emory University School of Medicine have identified a new type of potential anticancer drug. The compound, named FOBISIN, targets 14-3-3 proteins, important for the runaway growth of cancer cells.
Sep 12, 2011
0
76
